These results suggest that miR-299-3p is involved in regulation of VEGFA and promotes an antiangiogenic environment in PCa cells during combination treatment with DTX, which can have a potential impact in treatment of AR-independent CRPC. This evidence concerns the gene VEGFA and posterior cortical atrophy.